Steven N Fishbane (Steven Fishbane)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 14

Top Topics

Replacement Therapy

Chronic Kidney Disease

Ejection Fraction

Top Venues

Clinical journal of the American Society of Nephrology : CJASN

International journal of nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Steven N Fishbane, Hitesh H Shah
Automated Dialysis Anemia Management: Role of the Treating Nephrologist. Clinical journal of the American Society of Nephrology : CJASN (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Steven N Fishbane, Geoffrey A Block, Pieter Evenepoel, Jeffrey Budden, Isabelle Morin, Frédérique Menzaghi, Warren Wen, Edgar V Lerma
Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies. Kidney360 (2024)
Stuart M Sprague, Daniel E Weiner, David P Tietjen, Pablo E Pergola, Steven N Fishbane, Geoffrey A Block, Arnold L Silva, Stephen Z Fadem, Robert I Lynn, George Fadda, Lynae Pagliaro, Suling Zhao, Susan Edelstein, David M Spiegel, David P Rosenbaum
Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360 5 (5) (2024)
Steven N Fishbane, Juan Jesús Carrero, Supriya Kumar, Eiichiro Kanda, Katarina Hedman, Richard Ofori-Asenso, Naoki Kashihara, Mikhail Naum Kosiborod, Mitja Lainscak, Carol A Pollock, Stenvinkel Peter, David Collins Wheeler, Roberto Pecoits-Filho
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective Cohort. Kidney360 5 (7) (2024)
Steven N Fishbane, Michel Jadoul, Laura Dember, C P Kovesdy, Ayman Al-Shurbaji, Vera Lisovskaja, Priya Sekar, Brian Katona, Nicolas Guzman, Charles Herzog
Evaluation of the effect of sodium zirconium cyclosilicate on arrhythmia-related cardiovascular outcomes in patients receiving chronic haemodialysis with hyperkalaemia: protocol for the multicentre, randomised, controlled DIALIZE-Outcomes study. BMJ open 13 (5) (2023)
Bruce Spinowitz, Steven N Fishbane, Masafumi Fukagawa, Martin Ford, Nicolas Guzman, Anjay Rastogi
Course of Hyperkalemia in Patients on Hemodialysis. International journal of nephrology 2022 (2022)